• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Urolithin C

CAS No. 165393-06-6

Urolithin C ( —— )

产品货号. M29486 CAS No. 165393-06-6

Urolithin C is a gut metabolite of ellagic acid. Urolithin C induces apoptosis in PC12 cells through a mitochondria-mediated pathway.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥389 有现货
10MG ¥648 有现货
25MG ¥1183 有现货
50MG ¥2001 有现货
100MG ¥3013 有现货
200MG ¥4447 有现货
500MG ¥7039 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Urolithin C
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Urolithin C is a gut metabolite of ellagic acid. Urolithin C induces apoptosis in PC12 cells through a mitochondria-mediated pathway.
  • 产品描述
    Urolithin C is a gut metabolite of ellagic acid. Urolithin C induces apoptosis in PC12 cells through a mitochondria-mediated pathway.(In Vitro):Urolithin C is a glucose-dependent activator of insulin secretion acting by facilitating L-type Ca2+ channel opening and Ca2+ influx into pancreatic β-cells.Urolithin C enhanced glucose-induced extracellular signal-regulated kinases 1/2 (ERK1/2) activation as shown by higher phosphorylation levels in INS-1 β-cells. Urolithin C stimulates reactive oxygen species (ROS) formation.(In Vivo):In male Wistar rat, the half-life of the terminal part is 11.3 h and the total clearance (CL/F) is 3.41 L/h/kg. The initial volume of distribution (V1/F) is 0.831 L/kg and the steady-state volume of distribution (Vss/F) is 55.6 L/kg after the intraperitoneal administration of Urolithin C (10 mg/kg).
  • 同义词
    ——
  • 通路
    Apoptosis
  • 靶点
    Apoptosis
  • 受体
    Apoptosis
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    165393-06-6
  • 分子量
    244.2
  • 分子式
    C13H8O5
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    Oc1ccc2c(c1)oc(=O)c1cc(O)c(O)cc21
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • Dihydrorotenone

    Dihydrorotenone is a potent mitochondrial inhibitor and probably induces Parkinsonian syndrome.

  • TD52

    TD52 is an orally active inhibitor of cancerous inhibitor of PP2A (CIP2A). TD52 is an Erlotinib derivative and indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter.

  • LYN-1604 dihydrochlo...

    LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.